SUMMIT THERAPEUTICS
Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
SUMMIT THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2003-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.summittxinc.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1235 443 939
Total Funding:
1.06 B USD
Technology used in webpage:
DMARC Slack
Similar Organizations
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Redx Pharma
Redx Pharma is a drug discovery and development company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Synaptic Medical
Synaptic Medical is a medical device company.
Xeltis
Xeltis is a clinical-stage medtech company with the world’s most advanced polymer-based platform of restorative cardiovascular devices.
Current Advisors List
Board_member
2019-12-01
Current Employees Featured
Ankur Dhingra Chief Financial Officer @ Summit Therapeutics
Chief Financial Officer
2022-06-01
Laura Chow Senior Vice President Clinical Development @ Summit Therapeutics
Senior Vice President Clinical Development
2023-11-01
Nawaz Khan VP Anti-infectives Research @ Summit Therapeutics
VP Anti-infectives Research
2018-01-01
Manmeet S. Soni Chief Operating Officer @ Summit Therapeutics
Chief Operating Officer
2023-10-01
Maky Zanganeh Chief Operating Officer @ Summit Therapeutics
Chief Operating Officer
Robert W. Duggan Chief Executive Officer @ Summit Therapeutics
Chief Executive Officer
2020-02-01
Dave Gancarz Vice President, Investor Relations & Corporate Strategy @ Summit Therapeutics
Vice President, Investor Relations & Corporate Strategy
Dame Kay Davies Co-founder @ Summit Therapeutics
Co-founder
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-12-23 | Discuva | Discuva acquired by Summit Therapeutics | N/A |
| 2007-03-30 | DanioLabs | DanioLabs acquired by Summit Therapeutics | 30 M USD |
Investors List
Robert W. Duggan
Robert W. Duggan investment in Post-IPO Equity - Summit Therapeutics
Maky Zanganeh
Maky Zanganeh investment in Post-IPO Equity - Summit Therapeutics
CARB-X
CARB-X investment in Grant - Summit Therapeutics
Maky Zanganeh
Maky Zanganeh investment in Post-IPO Equity - Summit Therapeutics
Robert W. Duggan
Robert W. Duggan investment in Post-IPO Equity - Summit Therapeutics
Eurofarma
Eurofarma investment in Post-IPO Equity - Summit Therapeutics
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Post-IPO Equity - Summit Therapeutics
Robert W. Duggan
Robert W. Duggan investment in Post-IPO Equity - Summit Therapeutics
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Post-IPO Equity - Summit Therapeutics
CARB-X
CARB-X investment in Grant - Summit Therapeutics
Key Employee Changes
Official Site Inspections
http://www.summittxinc.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.13 K
- Host name: linux9.neonstone.com
- IP address: 141.94.254.149
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Summit Therapeutics"
Company - Summit Therapeutics
Summit Mission Statement To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory …See details»
Committed to being a leader in microbiome-preserving, precision ...
To build a viable, long -lasting health care organization that assumes full responsibility for designing, developing, trial enrollment, regulatory approval, and commercializing ...See details»
Summit Therapeutics, Inc. | LinkedIn
Summit Therapeutics, Inc. | 38,291 followers on LinkedIn. Summit Therapeutics’ mission is to resolve serious, unmet medical needs for the betterment of overall human health. | Summit …See details»
Summit Therapeutics - Crunchbase Company Profile & Funding
Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for …See details»
Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO
Jul 27, 2022 I am proud to serve alongside Maky and partner with her expertise as the co-leaders of this organization built with the purpose of improving the condition of overall human …See details»
Summit Therapeutics - Company Profile & Staff Directory
Summit Therapeutics is a biotechnology company located in 136a Eastern Avenue,Abingdon,Oxfordshire,GB with 196 employees. Access Summit Therapeutics's email …See details»
Summit Therapeutics CEO and Key Executive Team | Craft.co
Summit Therapeutics's Executive Chairman and Chief Executive Officer is Robert W. Duggan. Other executives include Maky Zanganeh, Co-Chief Executive Officer, President & Director; …See details»
Home - Summit Therapeutics
Phase 3 Clinical Studies Ivonescimab 2025 Annual Shareholders Meeting Great Place To Work Summit Therapeutics is proud to have achieved the Great Place to Work® Certification™! …See details»
CARB-X is funding Summit Therapeutics to develop a new …
May 18, 2021 First-in-class antibiotic to treat serious infections caused by pathogens identified as a ‘critical priority’ by the World Health Organization (WHO) and as an ‘urgent threat’ by the …See details»
Summit Therapeutics Presents Further Breakthrough Insights
Sep 30, 2021 Cambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an …See details»
About Us - Summit Therapeutics
About Us Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal …See details»
Leadership - Summit Therapeutics
Leadership Bob Duggan Co-CEO & Chairman Dr. Maky Zanganeh Co-CEO & President Summit Corporate Leaders Manmeet Soni Chief Operating Officer & Chief Financial Officer Dr. Fong …See details»
Executive Team - Summit Health
Meredith is the Chief Human Resources Officer for VillageMD, where she joined the organization in 2017. With over 20 years of experience in the healthcare and consulting industries, Meredith …See details»
Summit Therapeutics Announces Preclinical Candidate and …
Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has selected a new preclinical candidate, SMT026738 (“SMT-738”), for development in …See details»
Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh
Nov 23, 2020 Summit Therapeutics Inc. (‘Summit,’ the ‘Company,’ or the ‘Group’) Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating OfficerSee details»
summittxinc.com - Advancing Innovative Therapies.
Summittxinc.com most likely does not offer any adult content. Popular pages. Advancing Innovative Therapies | Summit Plc. We are a clinical-stage drug discovery and development …See details»
Summit Therapeutics Appoints Ankur Dhingra as Chief Financial …
Jun 1, 2022 Summit Therapeutics’ Mission Statement To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and …See details»
Summit Therapeutics Inc Reports Financial Results and
Mar 17, 2022 Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020: Revenue: $251 $185 $1,809 $860 Operating expenses:See details»
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, and …See details»
Pipeline - Summit Therapeutics
Ivonescimab Oncology Clinical Trials Globally over 2,300+ have been treated with ivonescimab across all clinical trials to date. Summit License Territories: United States, Canada, Europe, …See details»